Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -169,431 | -146,427 | -102,678 | -59,731 | -47,903 |
| Depreciation Amortization | 35,057 | 55,023 | 22,448 | 19,798 | 17,888 |
| Income taxes - deferred | N/A | N/A | N/A | -6,425 | -22,661 |
| Accounts receivable | 2,301 | -5,184 | 152 | 4,945 | -6,090 |
| Accounts payable and accrued liabilities | -6,036 | 9,255 | -2,708 | 2,060 | -2,916 |
| Other Working Capital | -26,042 | 2,624 | 10,613 | 3,814 | 5,211 |
| Other Operating Activity | 121,408 | 26,495 | 47,215 | 42,942 | 53,030 |
| Operating Cash Flow | $-42,743 | $-58,214 | $-24,958 | $7,403 | $-3,441 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 58,518 | 35,428 | -168,590 | 12,111 | -24,591 |
| PPE Investments | -6,767 | -195 | -727 | -887 | -1,428 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -615 |
| Purchase Of Investment | N/A | N/A | -15,000 | N/A | N/A |
| Purchase Sale Intangibles | -17,799 | -15,370 | -18,974 | -13,122 | -10,496 |
| Other Investing Activity | -113,078 | -15,370 | -18,974 | 34,378 | 37,004 |
| Investing Cash Flow | $-61,327 | $19,863 | $-203,291 | $45,602 | $10,370 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 235,797 | N/A | N/A |
| Common Stock Issued | 135,415 | 1,618 | 15,893 | 11,732 | 10,021 |
| Other Financing Activity | -7,702 | -3,695 | -19,827 | -6,287 | -13,870 |
| Financing Cash Flow | $127,713 | $-2,077 | $231,863 | $5,445 | $-3,849 |
| Exchange Rate Effect | -1,307 | -9 | -135 | -58 | 117 |
| Beginning Cash Position | 62,436 | 102,873 | 99,394 | 41,002 | 37,805 |
| End Cash Position | 84,772 | 62,436 | 102,873 | 99,394 | 41,002 |
| Net Cash Flow | $22,336 | $-40,437 | $3,479 | $58,392 | $3,197 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,743 | -58,214 | -24,958 | 7,403 | -3,441 |
| Capital Expenditure | -6,767 | -195 | -727 | -887 | -1,428 |
| Free Cash Flow | -49,510 | -58,409 | -25,685 | 6,516 | -4,869 |